Freedom Investment Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-2,573
| Closed | -$217K | – | 707 |
|
|
2019
Q2 | $217K | Sell |
2,573
-3,186
| -55% | -$269K | 0.02% | 615 |
|
|
2019
Q1 | $550K | Buy |
5,759
+1,197
| +26% | +$114K | 0.04% | 359 |
|
|
2018
Q4 | $323K | Buy |
4,562
+533
| +13% | +$37.7K | 0.03% | 552 |
|
|
2018
Q3 | $366K | Sell |
4,029
-441
| -10% | -$40.1K | 0.02% | 644 |
|
|
2018
Q2 | $518K | Sell |
4,470
-27,157
| -86% | -$3.15M | 0.03% | 536 |
|
|
2018
Q1 | $2.56M | Buy |
31,627
+528
| +2% | +$42.7K | 0.13% | 124 |
|
|
2017
Q4 | $1.83M | Buy |
31,099
+997
| +3% | +$58.5K | 0.09% | 176 |
|
|
2017
Q3 | $1.41M | Sell |
30,102
-1,463
| -5% | -$68.5K | 0.08% | 221 |
|
|
2017
Q2 | $1.14M | Buy |
31,565
+173
| +0.6% | +$6.23K | 0.06% | 270 |
|
|
2017
Q1 | $967K | Sell |
31,392
-3,934
| -11% | -$121K | 0.06% | 302 |
|
|
2016
Q4 | $1.18M | Sell |
35,326
-9,545
| -21% | -$320K | 0.07% | 205 |
|
|
2016
Q3 | $1.19M | Sell |
44,871
-1,144
| -2% | -$30.4K | 0.08% | 194 |
|
|
2016
Q2 | $1.02M | Sell |
46,015
-5,510
| -11% | -$122K | 0.07% | 216 |
|
|
2016
Q1 | $1.51M | Buy |
51,525
+6,689
| +15% | +$196K | 0.11% | 122 |
|
|
2015
Q4 | $1.48M | Buy |
44,836
+35,534
| +382% | +$1.17M | 0.11% | 132 |
|
|
2015
Q3 | $799K | Sell |
9,302
-11,612
| -56% | -$997K | 0.08% | 205 |
|
|
2015
Q2 | $941K | Buy |
+20,914
| New | +$941K | 0.1% | 168 |
|